Artisan Partners Limited Partnership Orchard Therapeutics PLC Transaction History

Artisan Partners Limited Partnership

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.42 - $0.78 $846,732 - $1.57 Million	-2,016,029 Reduced 37.76%	3,322,737 $1.94 Million
Q1 2022 May 13, 2022	SELL	$0.7 - $1.51 $3.13 Million - $6.76 Million	-4,477,342 Reduced 45.61%	5,338,766 $3.8 Million
Q4 2021 Feb 11, 2022	SELL	$1.16 - $2.23 $1.2 Million - $2.3 Million	-1,030,312 Reduced 9.5%	9,816,108 $13 Million
Q3 2021 Nov 12, 2021	SELL	$2.24 - $4.29 $5.82 Million - $11.1 Million	-2,596,612 Reduced 19.32%	10,846,420 $24.9 Million
Q2 2021 Aug 12, 2021	BUY	$4.39 - $7.23 $12.3 Million - $20.2 Million	2,799,242 Added 26.3%	13,443,032 $59 Million
Q1 2021 May 11, 2021	BUY	$4.39 - $9.08 $29.1 Million - $60.1 Million	6,617,980 Added 164.39%	10,643,790 $77.3 Million
Q4 2020 Feb 10, 2021	BUY	$3.86 - $5.07 $1.44 Million - $1.9 Million	374,251 Added 10.25%	4,025,810 $17.4 Million
Q3 2020 Nov 12, 2020	BUY	$4.11 - $6.45 $3.32 Million - $5.21 Million	807,692 Added 28.4%	3,651,559 $15 Million
Q2 2020 Aug 12, 2020	BUY	$5.75 - $11.99 $2 Million - $4.18 Million	348,507 Added 13.97%	2,843,867 $17.1 Million
Q1 2020 May 12, 2020	SELL	$5.65 - $15.71 $1.1 Million - $3.06 Million	-194,967 Reduced 7.25%	2,495,360 $18.8 Million
Q4 2019 Feb 12, 2020	BUY	$10.15 - $15.58 $9.59 Million - $14.7 Million	944,433 Added 54.09%	2,690,327 $37 Million
Q3 2019 Nov 12, 2019	BUY	$11.88 - $16.72 $979,612 - $1.38 Million	82,459 Added 4.96%	1,745,894 $20.7 Million
Q2 2019 Aug 09, 2019	BUY	$13.2 - $20.63 $22 Million - $34.3 Million	1,663,435 New	1,663,435 $23.3 Million

545K

Ticker ORTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,458,000
Description
Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...

Get notified when there are updates to the investment portfolio of Artisan Partners Limited Partnership, based on Form 13F filings with the SEC.

Stay updated on Artisan Partners Limited Partnership with notifications on news.